Finning reports Q2 2025 results, equipment backlog increases to $3 billion GlobeNewswire August 05, 2025 VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning”, the “Company”, “we”, “our” or “us”) reported second quarter 2025 results today. All monetary amounts are in Canadian dollars unless otherwise stated. During the three […]

NEW YORK CITY, NY / ACCESS Newswire / August 5, 2025 / Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of National Grid plc (NYSE:NGG) resulting from allegations that National Grid plc may have issued materially misleading business information to the investing public. SO

(NASDAQ:CFLT), Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 05, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Confluent, Inc. (“Confluent” or “the Company”) (NASDAQ: CFLT) investors that the firm has initiated an investigation into possible securities fraud and may file a class

Confluent, Inc. Investors: Company Investigated by the Portnoy Law Firm GlobeNewswire August 05, 2025 Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 05, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Confluent, Inc. (“Confluent” or “the Company”) (NASDAQ: CFLT) investors that the firm

Hyde Park Capitalannounced today that its client, Commercial Residential Aluminum (“CRA”), a leading vertically integrated designer, manufacturer, and installer of outdoor aluminum products serving both commercial and residential markets has been acquired by Garden City Equity (“Garden City”). Hyde Park Capital served as the exclusive investment banker to CRA for this transaction. Shumaker, Loop &

NEW YORK, NY / ACCESS Newswire / August 5, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=159856&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

(Neo:MOLY),(Boerse Frankfurt – Freiverkehr:2LF),(Neo:MOLY.NE),(Boerse Frankfurt – Freiverkehr:M0LY.F), NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) — Greenland Resources Inc. (“Greenland Resources” or the “Company“; Cboe CA: MOLY | FSE:

Greenland Resources Announces Closing of Private Placement Financing for Aggregate of $10 Million GlobeNewswire August 05, 2025 NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) — Greenland Resources Inc.

NEW YORK, NY / ACCESS Newswire / August 5, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=159855&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at

The TYK2 inhibitor market is expected to witness substantial growth in the coming years, driven by the increasing prevalence of autoimmune diseases, robust clinical pipeline activity, and expanding regulatory approvals. Several key players, including Takeda, Alumis, Priovant Therapeutics, and others, are involved in developing drugs for TYK2 inhibitors, such as Crohn's disease, psoriasis, dermatomyositis, and